AR064714A1 - Utilizacion de 10-[ (3r)-1- azabiciclo [2..2..2] oct-3- ilmetil) -1 0h- fenotiazina, par a la preparacion de un medicamento que ejerce una inhibicion selectiva de los receptores muscarinicos m1,m2 y m3 - Google Patents

Utilizacion de 10-[ (3r)-1- azabiciclo [2..2..2] oct-3- ilmetil) -1 0h- fenotiazina, par a la preparacion de un medicamento que ejerce una inhibicion selectiva de los receptores muscarinicos m1,m2 y m3

Info

Publication number
AR064714A1
AR064714A1 ARP070105989A ARP070105989A AR064714A1 AR 064714 A1 AR064714 A1 AR 064714A1 AR P070105989 A ARP070105989 A AR P070105989A AR P070105989 A ARP070105989 A AR P070105989A AR 064714 A1 AR064714 A1 AR 064714A1
Authority
AR
Argentina
Prior art keywords
oct
preparation
ilmetile
azabiciclo
phenotiazine
Prior art date
Application number
ARP070105989A
Other languages
English (en)
Spanish (es)
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of AR064714A1 publication Critical patent/AR064714A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ARP070105989A 2006-12-28 2007-12-28 Utilizacion de 10-[ (3r)-1- azabiciclo [2..2..2] oct-3- ilmetil) -1 0h- fenotiazina, par a la preparacion de un medicamento que ejerce una inhibicion selectiva de los receptores muscarinicos m1,m2 y m3 AR064714A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0656002A FR2910814B1 (fr) 2006-12-28 2006-12-28 Utilisation du 10-°(r3)-1-azabicyclo°2.2.2!oct-3-ylmethyl!-10h- phenothiazine pour la preparation d'un medicament exercant une inhibition selective des recepteurs muscariniques m1,2,3

Publications (1)

Publication Number Publication Date
AR064714A1 true AR064714A1 (es) 2009-04-22

Family

ID=37951872

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070105989A AR064714A1 (es) 2006-12-28 2007-12-28 Utilizacion de 10-[ (3r)-1- azabiciclo [2..2..2] oct-3- ilmetil) -1 0h- fenotiazina, par a la preparacion de un medicamento que ejerce una inhibicion selectiva de los receptores muscarinicos m1,m2 y m3

Country Status (21)

Country Link
US (1) US8143245B2 (enExample)
EP (1) EP2124956A1 (enExample)
JP (1) JP5564263B2 (enExample)
KR (1) KR101465277B1 (enExample)
CN (1) CN101573120B (enExample)
AR (1) AR064714A1 (enExample)
AU (1) AU2007341274B2 (enExample)
BR (1) BRPI0720591A2 (enExample)
CA (1) CA2674162A1 (enExample)
FR (2) FR2910814B1 (enExample)
IL (1) IL199557A (enExample)
MA (1) MA31026B1 (enExample)
MX (1) MX2009006950A (enExample)
NO (1) NO20092654L (enExample)
NZ (1) NZ577915A (enExample)
RU (1) RU2449794C2 (enExample)
TN (1) TN2009000257A1 (enExample)
TW (1) TWI423806B (enExample)
UA (1) UA98131C2 (enExample)
WO (1) WO2008080924A1 (enExample)
ZA (1) ZA200904304B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015133989A (ja) * 2015-04-28 2015-07-27 重泉 達志 健康食品
KR101969263B1 (ko) 2018-07-16 2019-04-15 이상호 산소 챔버용 산소 공급 장치

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1173445B (it) * 1984-03-16 1987-06-24 Guidotti & C Spa Labor Agenti ad attivita' antibroncospastica e composizioni farmaceutiche che li contengono
IT1251161B (it) * 1991-08-07 1995-05-04 Derivati ammonio quaternari di (-) e (+)-3-(10 h-fenotiazin-10-ilmetil)-l-azabiciclo (2.2.2.)ottano e composizioni farmaceutiche che li contengono
AU6686700A (en) 1999-08-23 2001-03-19 H. Lundbeck A/S Treatment of urinary incontinence
AU2002366800B2 (en) * 2001-12-20 2006-08-03 Femmepharma Holding Company, Inc. Vaginal delivery of drugs

Also Published As

Publication number Publication date
US8143245B2 (en) 2012-03-27
JP2010514730A (ja) 2010-05-06
KR101465277B1 (ko) 2014-11-27
MX2009006950A (es) 2009-07-14
AU2007341274A1 (en) 2008-07-10
RU2009128326A (ru) 2011-02-10
JP5564263B2 (ja) 2014-07-30
RU2449794C2 (ru) 2012-05-10
FR2953721A1 (fr) 2011-06-17
AU2007341274B2 (en) 2012-09-20
HK1133207A1 (en) 2010-03-19
BRPI0720591A2 (pt) 2014-02-25
NZ577915A (en) 2011-12-22
CN101573120A (zh) 2009-11-04
TWI423806B (zh) 2014-01-21
UA98131C2 (ru) 2012-04-25
KR20090103887A (ko) 2009-10-01
TN2009000257A1 (fr) 2010-10-18
WO2008080924A1 (fr) 2008-07-10
NO20092654L (no) 2009-09-28
EP2124956A1 (fr) 2009-12-02
FR2910814B1 (fr) 2011-06-17
CN101573120B (zh) 2011-11-23
TW200833331A (en) 2008-08-16
FR2910814A1 (fr) 2008-07-04
ZA200904304B (en) 2010-06-30
CA2674162A1 (fr) 2008-07-10
US20100063276A1 (en) 2010-03-11
MA31026B1 (fr) 2009-12-01
IL199557A (en) 2014-09-30

Similar Documents

Publication Publication Date Title
MX2010005931A (es) Profarmacos de tetrahidrocanabinol, composiciones que comprenden profarmacos de tetrahidrocanabinol y metodos para utilizar los mismos.
CL2007001427A1 (es) Sal de maleato de 5-amino-3-(2',3'-di-o-acetil-beta-d-ribofuranosil)-3h-tiazolo[4,5-d]pirimidin-2-ona; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de una infeccion po
GT200600445A (es) Formas de presentación farmaceuticas solidas de administración oral con liberacion rapida del principio activo.
CR9022A (es) Derivados de sulfonamida novedosos como moduladores de receptor de glucocorticoides para el tratamiento de enfermedades inflamatorias
AR051099A1 (es) Combinaciones terapeuticas que comprenden inhibidor de poli(adp-ribosa)polimerasas
BR112014014341A2 (pt) Intermediário metilado, seu método de preparação e seus usos, e composição farmacêutica
AR070299A1 (es) Derivados de pirazolopirimidinas como inhibidores de quinasas dependientes de ciclinas, usos y composiciones farmaceuticas
AR054347A1 (es) Combinaciones terapeuticas para el tratamiento o la prevencion de la depresion
AR060019A1 (es) Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo
BRPI0806863B8 (pt) uso de um éster de forbol na preparação de um medicamento para prevenção ou tratamento de uma infecção por hiv
MX2010002584A (es) Derivados de piperidina como agonistas de receptores muscarinicos.
UY33277A (es) Compuestos de anillo espiro-tetraciclico como moduladores de beta-secretasa y métodos de uso
MX2009001659A (es) Compuestos de 2,5-dihidroxibenceno para el tratamiento de rosacea.
AR062401A1 (es) Uso de derivados del 2,5-dihidroxibenceno para tratar dermatitis
UY31672A1 (es) "agonistas de receptores muscarínicos composiciones farmacéuticas métodos de tratamiento de los mismos, y procedimientos para su preparación"
AR064654A1 (es) Sales mono y hemi-sulfato de la 2-cl-4-[1-(4-fluor-fenil)-2,5-dimetil-1-h-imidazol-4-iletinil]-piridina y sus formas cristalinas y amorfas, antagonistas del receptor mg1ur5
AR058163A1 (es) Medicamentos exhaltadores del deseo sexual que comprenden derivados de benzimidazolona
CO6270217A2 (es) Formulaciones galenicas de alisquireno y valsartan
AR062390A1 (es) Uso de derivados del 2,5-dihidroxibenceno para el tratamiento de hemangiomas o hemangioblastomas
BRPI0816798A2 (pt) composto, composição farmacêutica, métodos para inibir a ação do glicogênio sintase cinase-3, e para tratar, prevenir ou melhorar uma doença, uso de um composto, e, artigo de fabricação
AR064543A1 (es) Uso de derivados de mononitrato de dianhidrohexita como agentes para el tratamiento de trastornos intestinales
DOP2006000287A (es) Derivados de piperidina
ECSP088801A (es) Composicion farmaceutica que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b para el tratamiento de la neuralgia
HN2010001775A (es) Composicion farmaceutica oral que comprende la combinacion de una sal de keterolaco y vitaminas del complejo b
AR074246A1 (es) Derivados de 1-amino-alquilciclohexano para el tratamiento de trastornos del sueno

Legal Events

Date Code Title Description
FB Suspension of granting procedure